Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal Safety of Sofosbuvir in Chronic HCV
NCT04169464Phase 4Unknown
- Sponsor
- Modern University for Technology and Information
- Start
- Apr 2019
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sofosbuvir in hepatitis C (HCV), sponsored by Modern University for Technology and Information. Primary endpoint: Occurrence of Acute Kidney Injury at 3 months. Status: unknown.
02
Drugs
sofosbuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04169464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04169464.